Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease-Reference-Cited by-同舟云学术

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease

Published:2019-06-17 Issue:1 Volume:13 Page:72-74
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

van der Vorm Lisa N¹²³^ORCID,Visser Ruben⁴,Huskens Dana¹²,Veninga Alicia²,Adams Denise L⁴,Remijn Jasper A¹³⁵,Hemker Hendrik C¹²,Rensma Pieter L⁴,van Horssen Remco⁶,de Laat Bas¹²³

Affiliation:

1. Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands

2. Synapse Research Institute, Maastricht, The Netherlands

3. Department of Clinical Chemistry and Hematology, Gelre Hospitals, Apeldoorn, The Netherlands

4. Department of Nephrology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands

5. Department of Clinical Chemistry, Meander Medical Center, Amersfoort, The Netherlands

6. Department of Clinical Chemistry and Hematology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/13/1/72/32500149/sfz076.pdf

Reference10 articles.

1. Chronic kidney disease increases risk for venous thromboembolism;Wattanakit;J Am Soc Nephrol,2008

2. Blood coagulation system in patients with chronic kidney disease: a prospective observational study;Huang;BMJ Open,2017

3. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain;Huizinga;Science,2002

4. The role of von Willebrand factor in thrombus formation;Ruggeri;Thromb Res,2007

5. The presence of active von Willebrand factor under various pathological conditions;Groot;Curr Opin Hematol,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombocytopenia and Bleeding in Chronic Kidney Disease: A Case of Acquired Von Willebrand Syndrome;Cureus;2024-07-31

2. Carbamylation Is Instrumental in End-Stage Kidney Disease Coagulopathies: The Impact on von Willebrand Factor and Platelet Functionality;Thrombosis and Haemostasis;2024-07-25

3. Endothelial dysfunction: molecular mechanisms and clinical implications;MedComm;2024-07-22

4. The impacts of dietary antioxidants on cardiovascular events in hemodialysis patients: An update on the cellular and molecular mechanisms;Nutrition Reviews;2024-05-10

5. Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications;Frontiers in Medicine;2023-11-14